Citeline Commercial

Discover the winning formula behind blockbuster drugs! Out of the 487 drugs approved in the US between 2014 and 2023, an impressive 193 are projected to exceed $1 billion in peak-year sales. Download your free copy: https://ow.ly/N3vo50SsXKK.

What pandemic? Industry-sponsored clinical trial activity has returned to pre-pandemic trends now that the turmoil of COVID-19 has abated. Find out more: https://ow.ly/K8i150Sl53u. Citeline’s annual analysis of completed clinical trials shows that the industry is back where it was at the end of the last decade. The focus on infectious diseases and vaccines has tapered off, and disruptions to other trials have come to an end. #ClinicalTrials #PharmaResearch #HealthcareNews #DrugDevelopment #ClinicalResearch

In the first of an ongoing series looking at quarterly dealmaking, BioBytes presents an overview of select AI-focused M&As, partnerships and financings in the biopharma industry in Q1 2024. Access an overview of the types of AI technologies pharma companies and investors are placing a premium on at the moment and who the big AI players are. Review the Q1 Deals: https://ow.ly/xuvj50RypQM. #BioPharmaAI #Biotech #VentureCapital #AIinHealthcare #TechInvesting #ArtificialIntelligence

Overcoming Obstacles and Seizing Opportunities in Early Phase Biotech Research. Access your free roundtable report now: https://ow.ly/kPSe50ShYcR. In this report in partnership with ICON plc, discover insights from leading biotechs on: • Different challenges of each development stage • CRO selection criteria and scoring tools • Additional CRO value vs. traditional value proposition #BiotechResearch #EarlyPhaseBiotech #RoundtableReport #BiotechInsights #ClinicalResearch #PharmaDevelopment

🌟Only two months left to enter the OTC Marketing Awards 2024! 🏆 Don't miss this opportunity to showcase your innovative marketing strategies and gain industry recognition. Enhance your brand visibility, network with industry leaders, and boost your company's reputation. Enter now and elevate your brand to new heights! 🚀 Entries closing on Friday, 6 September, 2024 For more details, visit: https://ow.ly/pIrH50Sun38 #OTCMarketingAwards

Final call for submitting your entries to the Scrip Awards 2024! 📢 The entry deadline for the 20th anniversary of the Awards is next week, Friday 12 July, 2024. 📆 Complete your entries before it's too late. Remember, only submitted entries will be accepted. Best of luck! #ScripAwards https://ow.ly/8ioq50SjMzY

Not long ago, the gap between China and the US in biotech was narrowing, but geopolitical tensions including growing suspicion between China and US authorities are having an impact on companies in the sector. This article analyzes the recent slide in share values and restrictions plans of China-based biotech companies, including contract research, development, and manufacturing companies. Read now: https://ow.ly/k92g50QKYBk #ChinaUSRelations #BiotechIndustry #HealthcareAnalysis

📣 Webinar replay available! Commercialising Cell and Gene Therapy bought to you by Citeline & the Indian Pharmaceutical Alliance (IPA). Access it now: https://ow.ly/7oYN50StWth. This illuminating webinar looks at one of the most active areas of research and investment in the development of medicine, Cell and Gene Therapy (CGT). The promising advancements in CGT present groundbreaking options for treating diseases like cancer, leading to tailored and affordable healthcare solutions for patients. Featuring Shridhar Narayanan - Technical Advisor, IPA , Pooja Rana - Senior Consultant at Citeline, Murali Ramachandra - CEO Aurigene and Rahul Purwar - Founder of ImmunoACT. #CellAndGeneTherapy #CancerTreatment #HealthcareInnovation #MedicalResearch #PharmaceuticalAlliance #BiotechAdvancements #WebinarReplay #IndianPharma

On the latest episode of HBW Insight's #OvertheCounter podcast, I had a super interesting chat with Bayer | Consumer Health's SVP Global Head Allergy, Cough/Cold, Pain and Heart Health, Reese Fitzpatrick, and head of R&D, North America and Therapeutics, Rachel Koontz about #Aspirin, which is celebrating its 125th anniversary this year. *[Link in the comments]* In terms of #Digital #Selfcare, for example, the firm is working with British medtech firm Huma on its Heart Health Risk Assessment app that it currently markets in the US and Middle East. Aspirin also still has #RxtoOTCswitch potential, they reveal, for example in markets like Mexico where the brand is not already available without a prescription. And if that’s not enough, we discuss Bayer’s extension of the Aspi brand into the #Naturals space, particularly in the cough and cold category in Europe. Citeline Commercial Martina Küng Jeff Donald Bayer

Some people aren't lucky enough to get a check-up every year 🩺 How can we help them understand their risk of a heart attack and how to take the proper actions to take better care of themselves? Our Global SVP of Heart Health, Reese Fitzpatrick shares: "As I think of where we go with Aspirin in the next 125 years, the word that pops to my mind, all the time, is ACCESS. How do we provide greater access? Access to education, access to proper tools to understand your own heart health risk, and then access to the actual products, Aspirin and beyond. What you can do to really take more control of your own health.” Reese and our Head of R&D for North America, Rachel Koontz talked with David Ridley from HBW Insight and Citeline Commercial about how we're transforming our 125 years old brand. Link to the podcast is in the comments.